查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
胰瘺治療的全球市場 - 成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1180735

胰瘺治療的全球市場 - 成長，未來展望，競爭分析(2022年～2030年)

Pancreatic Fistula Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

2021 年全球胰瘺治療市場規模預計為 20.9816 億美元，2022-2030 年預測期內復合年增長率為 5.7%。人們認為，胰瘺治療手術技術的廣泛採用將推動市場增長。

本報告提供全球胰瘺治療市場相關調查，提供市場趨勢，競爭資訊，市場區隔分析，新興趨勢，技術分析，企業簡介等資訊。

目錄

第1章 序文

  • 報告概要
  • 市場區隔
  • 調查手法

第2章 摘要整理

  • 市場概述:全球胰瘺治療市場
  • 全球胰瘺治療市場:不同治療(2021年)
  • 全球胰瘺治療市場:各地區(2021年)
  • 富有魅力的投資提案:各地區(2021年)

第3章 胰瘺治療市場:競爭分析

  • 主要的胰瘺治療市場供應商的市場定位
  • 胰瘺治療市場供應商的採用策略
  • 主要的產業策略
  • 階層分析:2021年VS2030年

第4章 胰瘺治療市場:常量分析和市場動態

  • 簡介
  • 全球胰瘺治療市場金額(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析

第5章 胰瘺治療市場:不同治療(2020年～2030年)

  • 市場概要
  • 成長和收益分析:2021年VS2030年
  • 市場區隔
    • 藥物

第6章 北美的胰瘺治療市場(2020年～2030年)

  • 市場概要
  • 胰瘺治療市場:不同治療(2020年～2030年)
  • 胰瘺治療市場:各地區(2020年～2030年)
    • 北美

第7章 英國·歐洲聯盟的胰瘺治療市場(2020年～2030年)

  • 市場概要
  • 胰瘺治療市場:不同治療(2020年～2030年)
  • 胰瘺治療市場:各地區(2020年～2030年)
    • 英國·歐洲聯盟

第8章 亞太地區的胰瘺治療市場(2020年～2030年)

  • 市場概要
  • 胰瘺治療市場:不同治療(2020年～2030年)
  • 胰瘺治療市場:各地區(2020年～2030年)
    • 亞太地區

第9章 南美的胰瘺治療市場(2020年～2030年)

  • 市場概要
  • 胰瘺治療市場:不同治療(2020年～2030年)
  • 胰瘺治療市場:各地區(2020年～2030年)
    • 南美

第10章 中東·非洲的胰瘺治療市場(2020年～2030年)

  • 市場概要
  • 胰瘺治療市場:不同治療(2020年～2030年)
  • 胰瘺治療市場:各地區(2020年～2030年)
    • 中東·非洲

第11章 企業簡介

  • Cook Medical, Inc.
  • Endo-Flex GmbH
  • CONMED Corporation
  • Fresenius Kabi AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Medtronic plc
  • Olympus Corporation
  • Novartis AG
  • Baxter International, Inc.
  • Ethicon USA, LLC
Product Code: 138219-08-22

Industry Outlook

The pancreatic fistula treatment market stood at US$ 2,098.16 Mn in 2021 and projected to exhibit compound annual growth rate (CAGR) of 5.7% during the forecast period from 2022 to 2030. The International Study Group for Pancreatic Fistulas (ISGPF), defines post-operative pancreatic fistula as 'external fistula with a drain output of any measurable volume after post-operative day three with an amylase level greater than three times the upper limit of the normal serum value'. Based on the clinical impact of the fistula on the patient's hospital stay duration and treatment outcome, pancreatic fistula is categorized into grade A, B and C. Acute and chronic pancreatitis are the major causative factors for pancreatic fistula (55%) followed by iatrogenic factors such as surgery, percutaneous drainage of pseudocysts, and biopsy (35%), and in rare cases trauma (10%). Administration of total parenteral nutrition and somatostatin analogs are the common measures used for treating pancreatic fistulas, followed by surgical intervention through ERCP and stenting; indicating unavailability of exclusive treatment option (either drug or device) specifically addressing pancreatic fistula. In the future, as the purview of minimally invasive procedures further proliferates the market may witness the emergence of new avenues.

Higher Adoption of Surgical Techniques for Pancreatic Fistula Treatment to Drive Market Growth

In 2021, surgical devices segment dominated the market owing to comparatively higher adoption of medical devices to diagnose and treat pancreatic fistula. In addition, extensive use of sphincterotome, biliary & pancreatic stents, guidewires, balloons, and cannulae while performing ERCP to manage pancreatic fistula is supporting the dominance of the ERCP devices segment. Total parenteral nutrition segment dominated the drugs segment attributed to augmented demand for parenteral nutrition products including single dose amino acid solution, carbohydrates, parenteral lipid emulsion, trace elements, vitamins, and minerals as it suppresses production of pancreatic enzymes by restricting the oral intake of food and maintains the nutrition of the patient. Increasing launches of generic drugs & pipeline of octreotide drugs in clinical trials are expected to support the market growth of drugs segment in the near future.

Increasing Healthcare Infrastructure in Asia Pacific to Drive the Growth during the forecast period

In 2021, North America accounted for the largest share in global pancreatic fistula treatment market, due to key driving factors such as rising prevalence of pancreatic cancer and pancreatic neuroendocrine tumors. With the growing incidences of pancreatic fistula, more number of research studies are being carried out in the region to enhance the usage of endotherapy to minimize the complication of pancreatic fistulae. High funding for R&D from the U.S. Federal Government coupled with presence of major medical device companies in the region would assist North America maintain its pole position during the forecast period. Asia Pacific emerged as the fastest growing region in the global pancreatic fistula treatment market owing to growing geriatric population susceptible to pancreatic cancer, adenocarcinoma, pancreatic neuroendocrine tumors and other gastrointestinal and lifestyle diseases. Growing healthcare infrastructure for efficient and preventive pancreatic surgeries will increase the demand for endoscopic retrograde cholangiopancreatography (ERCP) devices for the management of pre and post-operative complications related to pancreatic surgeries.

Market is studied in order to understand the current and future market trends in the pancreatic fistula treatment market. The market is estimated by providing the compounded annual growth rate (CAGR) and data forecast from 2022 to 2030. Product portfolio provided in the report gives information of the drugs and the surgical devices used in the treatment of pancreatic fistula. Strategic acquisition, merger and collaboration among the key players for developing innovative devices mentioned in the business strategy section. The key players currently engaged in the pancreatic fistula treatment market are Cook Medical, Inc., CONMED Corporation, Fresenius Kabi AG, B. Braun Melsungen Ag, Becton Dickinson & Company, Medtronic plc, Novartis AG and Others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pancreatic Fistula Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Pancreatic Fistula Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Market Segmentation

Treatment

Drugs

Octreotide

Total Parenteral Nutrition (TPN)

Drugs

Fibrin Sealant

Endoscopic Ultrasound (EUS) Guided Devices

Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices

Sphincterotome

Biliary & Pancreatic Stents

Accessories (Guidewires, Balloons & Cannulae)

Surgical Drainage Devices

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Pancreatic Fistula Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Pancreatic Fistula Treatment market?

Which is the largest regional market for Pancreatic Fistula Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Pancreatic Fistula Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Pancreatic Fistula Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Pancreatic Fistula Treatment Market
  • 2.2. Global Pancreatic Fistula Treatment Market, By Treatment, 2021 (US$ Million)
  • 2.3. Global Pancreatic Fistula Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Pancreatic Fistula Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Pancreatic Fistula Treatment Market Vendors
  • 3.2. Strategies Adopted by Pancreatic Fistula Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Pancreatic Fistula Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Pancreatic Fistula Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Drugs
      • 5.3.1.1. Octreotide
      • 5.3.1.2. Total Parenteral Nutrition (TPN)
    • 5.3.2. Drugs
      • 5.3.2.1. Fibrin Sealant
      • 5.3.2.2. Endoscopic Ultrasound (EUS) Guided Devices
      • 5.3.2.3. Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices
        • 5.3.2.3.1. Sphincterotome
        • 5.3.2.3.2. Biliary & Pancreatic Stents
        • 5.3.2.3.3. Accessories (Guidewires, Balloons & Cannulae)
      • 5.3.2.4. Surgical Drainage Devices

6. North America Pancreatic Fistula Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 6.3.Pancreatic Fistula Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

7. UK and European Union Pancreatic Fistula Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 7.3.Pancreatic Fistula Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

8. Asia Pacific Pancreatic Fistula Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 8.3.Pancreatic Fistula Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

9. Latin America Pancreatic Fistula Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 9.3.Pancreatic Fistula Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

10. Middle East and Africa Pancreatic Fistula Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 10.3.Pancreatic Fistula Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Pancreatic Fistula Treatment Market: By Treatment, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Cook Medical, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Endo-Flex GmbH
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. CONMED Corporation
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Fresenius Kabi AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. B. Braun Melsungen AG
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Becton, Dickinson and Company
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Medtronic plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Olympus Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Novartis AG
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Baxter International, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Ethicon USA, LLC
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 2 Global Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 3 Global Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 4 Global Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 5 North America Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 6 North America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 7 North America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 8 North America Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 9 U.S. Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 10 U.S. Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 11 U.S. Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 12 U.S. Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 13 Canada Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 14 Canada Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 15 Canada Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 16 Canada Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 17 Rest of North America Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 21 UK and European Union Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 25 UK Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 26 UK Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 27 UK Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 28 UK Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 29 Germany Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 30 Germany Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 31 Germany Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 32 Germany Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 33 Spain Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 34 Spain Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 35 Spain Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 36 Spain Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 37 Italy Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 38 Italy Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 39 Italy Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 40 Italy Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 41 France Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 42 France Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 43 France Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 44 France Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 49 Asia Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 50 Asia Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 51 Asia Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 52 Asia Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 53 China Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 54 China Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 55 China Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 56 China Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 57 Japan Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 58 Japan Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 59 Japan Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 60 Japan Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 61 India Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 62 India Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 63 India Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 64 India Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 65 Australia Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 66 Australia Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 67 Australia Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 68 Australia Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 69 South Korea Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 70 South Korea Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 71 South Korea Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 72 South Korea Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 73 Latin America Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 74 Latin America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 75 Latin America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 76 Latin America Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 77 Brazil Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 78 Brazil Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 79 Brazil Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 80 Brazil Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 81 Mexico Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 82 Mexico Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 83 Mexico Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 84 Mexico Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 93 GCC Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 94 GCC Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 95 GCC Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 96 GCC Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 97 Africa Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 98 Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 99 Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 100 Africa Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Pancreatic Fistula Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Pancreatic Fistula Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Pancreatic Fistula Treatment Market By Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Pancreatic Fistula Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Pancreatic Fistula Treatment Market: Quality Assurance
  • FIG. 5 Global Pancreatic Fistula Treatment Market, By Treatment, 2021
  • FIG. 6 Global Pancreatic Fistula Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Pancreatic Fistula Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Pancreatic Fistula Treatment Market Players, 2021
  • FIG. 9 Global Pancreatic Fistula Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Pancreatic Fistula Treatment Market, By Treatment, 2021 Vs 2030, %
  • FIG. 11 U.S. Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Pancreatic Fistula Treatment Market (US$ Million), 2020 - 2030